pubmed-article:19153534 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0023545 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0149783 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C1516451 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C1514623 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0442796 | lld:lifeskim |
pubmed-article:19153534 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
pubmed-article:19153534 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19153534 | pubmed:dateCreated | 2009-2-27 | lld:pubmed |
pubmed-article:19153534 | pubmed:abstractText | The addition of leukotriene modifier (LM) may be a useful approach for uncontrollable asthma despite treatment with inhaled corticosteroid (ICS), especially in asthmatics comorbid with allergic rhinitis (AR), although little is known about its molecular mechanism. We evaluated the additive effects of LM with ICS on pulmonary function and airway inflammation in asthmatics with or without AR. | lld:pubmed |
pubmed-article:19153534 | pubmed:language | eng | lld:pubmed |
pubmed-article:19153534 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19153534 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19153534 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19153534 | pubmed:issn | 1323-8930 | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:MatsunagaKazu... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:MinakataYoshi... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:IchinoseMasak... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:KoaraiAkiraA | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:SugiuraHisato... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:YanagisawaSat... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:IchikawaTomoh... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:HiranoTsunahi... | lld:pubmed |
pubmed-article:19153534 | pubmed:author | pubmed-author:AkamatsuKeiic... | lld:pubmed |
pubmed-article:19153534 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19153534 | pubmed:volume | 58 | lld:pubmed |
pubmed-article:19153534 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19153534 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19153534 | pubmed:pagination | 89-96 | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:meshHeading | pubmed-meshheading:19153534... | lld:pubmed |
pubmed-article:19153534 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19153534 | pubmed:articleTitle | Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy. | lld:pubmed |
pubmed-article:19153534 | pubmed:affiliation | Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Wakayama, Japan. | lld:pubmed |
pubmed-article:19153534 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19153534 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |